Jump to main content
Jump to site search

Issue 53, 2016
Previous Article Next Article

Polyethylenimine incorporation into hydrogel nanomatrices for enhancing nanoparticle-assisted chemotherapy

Author affiliations

Abstract

The efficacy of drug-loaded nanoparticles (NPs) for cancer therapy is related to (1) the cellular uptake of the NPs, (2) the ability to control drug release, and (3) the ability to deliver drugs to the cytosol, while evading the endosomal compartments. Here we present a NP carrier of cisplatin, made of poly(acrylamide-co-N-(3-aminopropyl)methacrylamide) (PAA) and a branched polyethylenimine (PEI), a source of primary, secondary, as well as tertiary amine groups. We found that (1) the cellular uptake of the NPs was highly enhanced by the PEI incorporation. However, surprisingly, this is not due to significant changes to the NP surface charge (zeta potential). Also, the PEI-incorporation into the PAA NPs resulted in (2) an accelerated release kinetics, (3) an ability to destabilize the endosomal/lysosomal membrane, and (4) a marginal increase in drug loading. The combination of the 4 aforementioned effects seems to account for the observed significant increase in the cytotoxicity of these cisplatin-loaded PEI-incorporated NPs, when applied to the 9L glioma cell line.

Graphical abstract: Polyethylenimine incorporation into hydrogel nanomatrices for enhancing nanoparticle-assisted chemotherapy

Back to tab navigation

Publication details

The article was received on 26 Jan 2016, accepted on 08 May 2016 and first published on 09 May 2016


Article type: Paper
DOI: 10.1039/C6RA02414A
Citation: RSC Adv., 2016,6, 48016-48024
  •   Request permissions

    Polyethylenimine incorporation into hydrogel nanomatrices for enhancing nanoparticle-assisted chemotherapy

    T. Shirakura, A. Ray and R. Kopelman, RSC Adv., 2016, 6, 48016
    DOI: 10.1039/C6RA02414A

Search articles by author

Spotlight

Advertisements